Graft versus Leukemia in 2023.
Chiad Z, Chojecki A.
Best Pract Res Clin Haematol. 2023 Sep;36(3):101476. doi: 10.1016/j.beha.2023.101476. Epub 2023 Jun 10.
The graft-versus-leukemia effect.
Mavroudis D, Barrett J.
Curr Opin Hematol. 1996 Nov;3(6):423-9. doi: 10.1097/00062752-199603060-00005.
Naive T Cells in Graft Versus Host Disease and Graft Versus Leukemia: Innocent or Guilty?
Dekker L, Sanders E, Lindemans CA, de Koning C, Nierkens S.
Front Immunol. 2022 Jun 20;13:893545. doi: 10.3389/fimmu.2022.893545. eCollection 2022.
Graft-versus-leukemia reactions in clinical bone marrow transplantation.
Mehta J.
Leuk Lymphoma. 1993 Aug;10(6):427-32. doi: 10.3109/10428199309148199.
Strategies for Enhancing and Preserving Anti-leukemia Effects Without Aggravating Graft-Versus-Host Disease.
Chang YJ, Zhao XY, Huang XJ.
Front Immunol. 2018 Dec 21;9:3041. doi: 10.3389/fimmu.2018.03041. eCollection 2018.
Protocols for Studying Graft-Versus-Leukemia Immunity in Mice.
Sena CL, Gondim IO, Ferreira EP, da Silva SB, Antunes MM, Castor MGM, Rezende BM.
Methods Mol Biol. 2025;2907:315-332. doi: 10.1007/978-1-0716-4430-0_15.
[Graft-versus-leukemia reactions].
Ju X, Wang J.
Zhonghua Xue Ye Xue Za Zhi. 1999 Aug;20(8):443-5.
Graft-versus-leukemia following bone marrow transplantation.
Butturini A, Bortin MM, Gale RP.
Bone Marrow Transplant. 1987 Oct;2(3):233-42.
Graft versus leukemia in humans.
Butturini A, Gale RP.
Cancer Treat Res. 1995;76:299-314. doi: 10.1007/978-1-4615-2013-9_14.
Sleeping Beauty-engineered CAR T cells achieve antileukemic activity without severe toxicities.
Magnani CF, Gaipa G, Lussana F, Belotti D, Gritti G, Napolitano S, Matera G, Cabiati B, Buracchi C, Borleri G, Fazio G, Zaninelli S, Tettamanti S, Cesana S, Colombo V, Quaroni M, Cazzaniga G, Rovelli A, Biagi E, Galimberti S, Calabria A, Benedicenti F, Montini E, Ferrari S, Introna M, Balduzzi A, Valsecchi MG, Dastoli G, Rambaldi A, Biondi A.
J Clin Invest. 2020 Nov 2;130(11):6021-6033. doi: 10.1172/JCI138473.
